ImageneBio (IMA) Interest Coverage Ratio (2020 - 2025)
ImageneBio (IMA) posted Interest Coverage Ratio of 9.18 for Q3 2025, up 97.69% sequentially from 397.73 in Q2 2025, and down 183.6% YoY from 10.98 in Q3 2024.
ImageneBio (IMA) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
ImageneBio has reported Interest Coverage Ratio for 6 years, with the latest figure at 9.18 in Q3 2025.
- Quarterly Interest Coverage Ratio fell 183.6% year-over-year to 9.18 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 23.97 (up 74.0% YoY) and the FY2024 annual result came in at 0.53, up 29.17% from the prior year.
- Interest Coverage Ratio rose to 9.18 in Q3 2025 per IMA's latest filing, from 397.73 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.08 in Q4 2021 and troughed at 399.67 in Q1 2025.
- A 5-year average of 49.63 and a median of 4.8 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2023: Interest Coverage Ratio surged 101.76% in 2021, then plunged 27641.72% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 0.08 in 2021, then plunged by 10328.75% to 8.58 in 2022, then declined by 1.05% to 8.67 in 2023, then gained by 20.53% to 6.89 in 2024, then sank by 33.18% to 9.18 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 9.18, 397.73, and 399.67 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | ImageneBio | 48.60 Mn | -86.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -9.18 |
| Jun 30, 2025 | -397.73 |
| Mar 31, 2025 | -399.67 |
| Dec 31, 2024 | -6.89 |
| Sep 30, 2024 | -3.24 |
| Jun 30, 2024 | -33.24 |
| Mar 31, 2024 | -58.23 |
| Dec 31, 2023 | -8.67 |
| Sep 30, 2023 | -4.80 |
| Jun 30, 2023 | -1.52 |
| Mar 31, 2023 | -7.62 |
| Dec 31, 2022 | -8.58 |
| Sep 30, 2022 | -0.02 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | -2.93 |
| Dec 31, 2021 | 0.08 |
| Sep 30, 2021 | -0.42 |
| Jun 30, 2021 | -0.31 |
| Mar 31, 2021 | -0.09 |
| Dec 31, 2020 | -4.77 |